The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
DNA Methylation and Cancer
Abstract
DNA methylation is an important regulator of gene transcription, and its role in carcinogenesis has been a topic of considerable interest in the last few years. Alterations in DNA methylation are common in a variety of tumors as well as in development. Of all epigenetic modifications, hypermethylation, which represses transcription of the promoter regions of tumor suppressor genes leading to gene silencing, has been most extensively studied. However, global hypomethylation has also been recognized as a cause of oncogenesis. New information concerning the mechanism of methylation and its control has led to the discovery of many regulatory proteins and enzymes. The contribution of dietary folate and methylene terahydrofolate reductase polymorphisms to methylation patterns in normal and cancer tissues is under intense investigation. As methylation occurs early and can be detected in body fluids, it may be of potential use in early detection of tumors and for determining the prognosis. Because DNA methylation is reversible, drugs like 5′-azacytidine, decitabine, and histone deacetylase inhibitors are being used to treat a variety of tumors. Novel demethylating agents such as antisense DNA methyl transferase and small interference RNA are being developed, making the field of DNA methylation wider and more exciting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“mice developed aggressive T-cell lymphomas that displayed a high frequency of chromosome 15 trisomy.(22) Therefore,”
BackgroundHerman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
A histone H3 methyltransferase controls DNA methylation in Neurospora crassa
Tamaru, H., & Selker, E. U. (2001) · Nature · doi:10.1038/35104508 · Cited by 1,038
Number of CpG islands and genes in human and mouse.
Antequera, F., & Bird, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11995 · Cited by 996
Ramsahoye, B. H., Biniszkiewicz, D., Lyko, F., Clark, V., Bird, A. P., & Jaenisch, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5237 · Cited by 970
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
Ng, H.-H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., & Bird, A. (1999) · Nature Genetics · doi:10.1038/12659 · Cited by 936
Friso, S., Choi, S.-W., Girelli, D., Mason, J. B., Dolnikowski, G. G., Bagley, P. J., Olivieri, O., Jacques, P. F., Rosenberg, I. H., Corrocher, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062066299 · Cited by 932
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gegonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787
Effects of DNA methylation on DNA-binding proteins and gene expression
Tate, P. H., & Bird, A. P. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90027-m · Cited by 737 · cited 1×
“contain CpG residues, and binding of each has been shown to be inhibited by methylation.(1,25)”
BackgroundThe DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
Hansen, R. S., Wijmenga, C., Luo, P., Stanek, A. M., Canfield, T. K., Weemaes, C. M. R., & Gartler, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14412 · Cited by 735
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700
Jüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665
Veigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J. D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P. L., Sedwick, W. D., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8698 · Cited by 648
A mammalian protein with specific demethylase activity for mCpG DNA
Bhattacharya, S. K., Ramchandani, S., Cervoni, N., & Szyf, M. (1999) · Nature · doi:10.1038/17533 · Cited by 620
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M.-F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2003) · Nature Genetics · doi:10.1038/ng1068 · Cited by 614
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman, J. G., Jen, J., Merlo, A. U., & Baylin, S. B. (1996) · PubMed · Cited by 571
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor
Prokhortchouk, A., Hendrich, B., Jørgensen, H., Ruzov, A., Wilm, M., Georgiev, G., Bird, A., & Prokhortchouk, E. (2001) · Genes & Development · doi:10.1101/gad.198501 · Cited by 533
A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.
Chen, J., Giovannucci, E. L., Kelsey, K. T., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Spiegelman, D. L., Willett, W. C., & Hunter, D. J. (1996) · PubMed · Cited by 516
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Köhler, G., Wijermans, P., Jones, P. A., & Lübbert, M. (2002) · Blood · doi:10.1182/blood.v100.8.2957 · Cited by 514
Plumb, J. A., Strathdee, G. R., Sludden, J., Kaye, S. B., & Brown, R. E. (2000) · PubMed · doi:10.25405/ncl.34284429 · Cited by 486
DNA methylation and chromatin – unraveling the tangled web
Robertson, K. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205609 · Cited by 471
Cross, S. H., & Bird, A. P. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80044-1 · Cited by 450
Piekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
Costello, J. F., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 442
DNA Methylation: A Profile of Methods and Applications
Fraga, M. F., & Esteller, M. (2002) · BioTechniques · doi:10.2144/02333rv01 · Cited by 422
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Santini, V., Kantarjian, H. M., & Issa, J.-P. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00011 · Cited by 414
Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204175 · Cited by 376
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
Kawakami, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1805 · Cited by 376
Maruyama, R., Toyooka, S., Toyooka, K. O., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Minna, J. D., McConnell, J. D., Frenkel, E. P., & Gazdar, A. F. (2002) · PubMed · Cited by 370
Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic, A., & Simpfendorfer, D. (1997) · PubMed · Cited by 370
Bailey, L. B., & Gregory, J. F. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.5.919 · Cited by 369
Singal, R., & Ginder, G. D. (1999) · Blood · doi:10.1182/blood.v93.12.4059 · Cited by 365
Self-citationConcurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki, J. R., Vincent, P., & Clark, S. J. (1999) · PubMed · Cited by 359
Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Esteller, M., Corn, P. G., Ureña, J. M., Gabrielson, E. W., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 356
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
Fahrner, J. A., Eguchi, S., Herman, J. G., & Baylin, S. B. (2002) · PubMed · Cited by 353
Strathdee, G., MacKean, M. J., Illand, M., & Brown, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202540 · Cited by 350
Wiemels, J. L., Smith, R. N., Taylor, G. M., Eden, O. B., Alexander, F. E., Greaves, M. F., & United Kingdom Childhood Cancer Study Investigators (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061408298 · Cited by 339
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
Evron, E., Dooley, W. C., Umbricht, C. B., Rosenthal, D., Sacchi, N., Gabrielson, E., Soito, A. B., Hung, D. T., Ljung, B.-M., Davidson, N. E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04501-3 · Cited by 333
Methylation profiling in acute myeloid leukemia
Toyota, M., Kopecky, K. J., Toyota, M.-O., Jair, K.-W., Willman, C. L., & Issa, J.-P. J. (2001) · Blood · doi:10.1182/blood.v97.9.2823 · Cited by 324
Goessl, C. D., Krause, H., Müller, M., Heicappell, R., Schrader, M. G., Sachsinger, J., & Miller, K. (2000) · PubMed · Cited by 304
He, L.-Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11537 · Cited by 303
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
DNA methylation analysis: a powerful new tool for lung cancer diagnosis
Tsou, J. A., Hagen, J. A., Carpenter, C. L., & Laird-Offringa, I. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205605 · Cited by 296
DNA methylation and gene silencing in cancer: which is the guilty party?
Clark, S. J., & Melki, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205598 · Cited by 287
DNA methyltransferase inhibitors—state of the art
Goffin, J., & Eisenhauer, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf314 · Cited by 283
Arnold, C. N., Goel, A., & Boland, C. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11176 · Cited by 280
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker, C., Millar, D., Paul, C. L., Warnecke, P. M., Harrison, E. M., Vincent, P., Frommer, M., & Clark, S. J. (1997) · PubMed · Cited by 272
Hypermethylation of the p15INK4B Gene in Myelodysplastic Syndromes
Uchida, T., Kinoshita, T., Nagai, H., Nakahara, Y., Saito, H., Hotta, T., & Murate, T. (1997) · Blood · doi:10.1182/blood.v90.4.1403 · Cited by 269
Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong, J., Lo, K. W., To, K., Teo, P. M. L., Johnson, P. J., & Huang, D. P. (2002) · PubMed · Cited by 259
Genome-wide hypomethylation in hepatocellular carcinogenesis.
Lin, C. H., Hsieh, S., Sheen, I., Lee, W. C., Chen, T. C., Shyu, W. C., & Liaw, Y. (2001) · PubMed · Cited by 246
Virmani, A. K., Rathi, A., Sathyanarayana, U. G., Padar, A., Huang, C., Cunnigham, H. T., Farinas, A. J., Milchgrub, S., Euhus, D., Gilcrease, M. Z., et al. (2001) · PubMed · Cited by 245
Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
Silva, J. M. R., Dominguez, G., Garcia, J. M., Gonzalez, R. M., Villanueva, M. J., Navarro, F., Provencio, M., Martin, S., España, P., & Bonilla, F. (1999) · PubMed · Cited by 236
Kantarjian, H. M., O'Brien, S., Cortes, J., Giles, F. J., Faderl, S., Issa, J., Garcia‐Manero, G., Rios, M. B., Shan, J., Andreeff, M., et al. (2003) · Cancer · doi:10.1002/cncr.11543 · Cited by 227
Hypomethylation of DNA in pathological conditions of the human prostate.
Bedford, M. T., & van Helden, P. D. (1987) · PubMed · Cited by 219
DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients
Tuck-Muller, C. M., Narayan, A., Tsien, F., Smeets, D. F. C. M., Sawyer, J., Fiala, E. S., Sohn, O. S., & Ehrlich, M. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015590 · Cited by 209
Segura-Pacheco, B. A., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Mariscal, I., Chavez, A., Acuña, C., Salazar, A. M., Lizano, M., & Dueñas‐González, A. (2003) · PubMed · Cited by 206
DNA methylation in breast cancer.
Yang, X., Yan, L., & Davidson, N. E. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080115 · Cited by 204
Tying It All Together: Epigenetics, Genetics, Cell Cycle, and Cancer
Baylin, S. B. (1997) · Science · doi:10.1126/science.277.5334.1948 · Cited by 202
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
Leone, G. G. M., Teofili, L., Voso, M. T., & Lübbert, M. (2002) · PubMed · Cited by 200
Christman, J. K., Sheikhnejad, G., Dizik, M., Abileah, S., & Wainfan, E. (1993) · Carcinogenesis · doi:10.1093/carcin/14.4.551 · Cited by 199
Morrissey, C., Martinez, A., Zatyka, M., Agathanggelou, A., Honorio, S., Astuti, D., Morgan, N. V., Moch, H., Richards, F. M., Kishida, T., et al. (2001) · PubMed · Cited by 197
Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma
Kim, Y., Giuliano, A. R., Hatch, K. D., Schneider, A., Nour, M., Dallal, G. E., Selhub, J., & Mason, J. B. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3<893::aid-cncr2820740316>3.0.co;2-b · Cited by 196
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000) · PubMed · Cited by 190
Kersting, M., Friedl, C., Kraus, A., Behn, M., Pankow, W., & Schuermann, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3221 · Cited by 181
Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou, H., Yu, B.-M., Wang, Z., Sun, J., Cang, H., Gao, F., Li, D. H., Zhao, R., Feng, G.-G., & Yi, J. (2002) · PubMed · Cited by 179
Lübbert, M. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_9 · Cited by 169
Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden, S., Tokumaru, Y., Westra, W. H., Goodman, S. N., Ahrendt, S. A., Yang, S. C., & Sidransky, D. (2003) · PubMed · Cited by 167
Pogribny, I. P., Miller, B., & James, S. J. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04708-3 · Cited by 157
Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.
Li, L. C., Chui, R. M., Nakajima, K., Oh, B. R., Au, H. C., & Dahiya, R. (2000) · PubMed · Cited by 150
Promoter Methylation Status of E-Cadherin, hMLH1, and p16 Genes in Nonneoplastic Gastric Epithelia
Waki, T., Tamura, G., Tsuchiya, T., Sato, K., Nishizuka, S., & Motoyama, T. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64195-8 · Cited by 147
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan, K. Y. K., Özçelik, H., Cheung, A., Ngan, H., & Khoo, U. (2002) · PubMed · Cited by 132
Villuendas, R., Sánchez‐Beato, M., Martínez, J. C., Sáez, A. I., Martínez–Delgado, B., García, J. F., Mateo, M. S., Sánchez‐Verde, L., Benitez, J. J., Martínez, P., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65630-1 · Cited by 132
Singal, R., van Wert, J., & Bashambu, M. (2001) · PubMed · Cited by 129
Self-citationBRCA1 methylation: a significant role in tumour development?
Catteau, A., & Morris, J. R. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00056-1 · Cited by 122
Wilson, V. L., Jones, P. A., & Momparler, R. L. (1983) · PubMed · Cited by 118
Sato, N., Maehara, N., Su, G. H., & Goggins, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.4.327 · Cited by 118
Domínguez, G., Carballido, J., Silva, J., Silva, J. M., García, J. M., Menéndez, J., Provencio, M., España, P., & Bonilla, F. (2002) · PubMed · Cited by 114
Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.
Jürgens, B., Schmitz‐Dräger, B. J., & Schulz, W. A. (1996) · PubMed · Cited by 112
Gershoni‐Baruch, R., Dagan, E., Israeli, D., Kasinetz, L., Kadouri, E., & Friedman, E. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00306-3 · Cited by 109
Differential methylation of human LINE-1 retrotransposons in malignant cells
Alves, G., Tatro, A. V., & Fanning, T. G. (1996) · Gene · doi:10.1016/0378-1119(96)00205-3 · Cited by 108
DNA Methyltransferase Deficiency Modifies Cancer Susceptibility in Mice Lacking DNA Mismatch Repair
Trinh, B. N., Long, T. I., Nickel, A. E., Shibata, D. K., & Laird, P. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2906-2917.2002 · Cited by 102
Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients
Nakayama, H., Hibi, K., Taguchi, M., Takase, T., Yamazaki, T., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00839-4 · Cited by 101
Targeting DNA methylation in cancer
Szyf, M. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00012-6 · Cited by 101
Sibani, S., Christensen, B., O’Ferrall, E., Saadi, I., Hiou-Tim, F., Rosenblatt, D. S., & Rozen, R. (2000) · Human Mutation · Cited by 96
Singal, R., Ferris, R. C., Little, J. A., Wang, S. Z., & Ginder, G. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13724 · Cited by 95
Self-citationKim, Y.-I., Pogribny, I. P., Salomon, R., Choi, S., Smith, D. E., James, S. J., & Mason, J. B. (1996) · Europe PMC (PubMed Central) · Cited by 87
DNA Methylation as a Target for Drug Design
Bender, C. M., Zingg, J.-M., & Jones, P. A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011946030404 · Cited by 87
Antequera, F., & Bird, A. P. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9118-9_8 · Cited by 81
LINE-1: a human transposable element
Singer, M., Krek, V., McMillan, J., Swergold, G. D., & Thayer, R. E. (1993) · Gene · doi:10.1016/0378-1119(93)90064-a · Cited by 71
González‐Gómez, P., Bello, M. J., Alonso, M. E., Arjona, D., Lomas, J. S., de Campos, J. M., Isla, A., & REY, J. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600737 · Cited by 63
Frémont, M., Siegmann, M., Gaulis, S., Matthies, R., Hess, D., & Jost, J. P. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2375 · Cited by 62
5-AZA-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation
Momparler, R. L., Bouchard, J., Onetto-Pothier, N., & Rivard, G. (1984) · Leukemia Research · doi:10.1016/0145-2126(84)90141-3 · Cited by 61
García, M. J., Martínez–Delgado, B., Cebrián, A., Martínez, Á., Benitez, J. J., & Rivas, C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64261-7 · Cited by 59
Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer
Ng, C. S. H., Zhang, J., Wan, S., Lee, T. W., Arifi, A. A., Mok, T. S. K., Lo, D., & Yim, A. P. C. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10046 · Cited by 58
Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?
Prokhortchouk, E., & Hendrich, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205631 · Cited by 56
Marugame, T., Tsuji, E., Kiyohara, C., Eguchi, H., Oda, T., Shinchi, K., & Kono, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg004 · Cited by 52
Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival
Maeda, K., Kawakami, K., Ishida, Y., Ishiguro, K., Omura, K., & Watanabe, G. (2003) · Oncology Reports · doi:10.3892/or.10.4.935 · Cited by 46
Singal, R., Wang, S. Z., Sargent, T. G., Zhu, S. Z., & Ginder, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105580200 · Cited by 45
Self-citationD’Incalci, M., Covey, J. M., Zaharko, D. S., & Kohn, K. W. (1985) · PubMed · Cited by 38
Epigenetic cancer therapies: DNA methyltransferase inhibitors
Brown, R., & Strathdee, G. R. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.6.747 · Cited by 32
Manev, H., & Uz, T. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01711-9 · Cited by 23
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Cancer biomarker detection: recent achievements and challenges
Wu, L., & Qu, X. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00370e · Cited by 1,214
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
Metadata
- Authors
- Das, P. M., & Singal, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-11-15
- Volume
- 22
- Issue
- 22
- Pages
- 4632-4642
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2046387526
- Cited by
- 1,456
- References
- 124
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.